vs
Astrana Health, Inc.（ASTH）とHuron Consulting Group Inc.（HURN）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $442.0M、Huron Consulting Group Inc.の約2.2倍）。Huron Consulting Group Inc.の純利益率が高く（6.9% vs 0.7%、差は6.2%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 10.7%）。Huron Consulting Group Inc.の直近四半期フリーキャッシュフローが多い（$123.8M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 10.3%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
ヒューロン・コンサルティング・グループは、ヘルスケア、ライフサイエンス、商業、高等教育の4分野を中心に経営コンサルティングサービスを提供する専門企業で、顧客の課題解決と持続的な成長を支援しています。
ASTH vs HURN — 直接比較
損益計算書 — Q4 2025 vs Q4 2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $442.0M |
| 純利益 | $6.6M | $30.7M |
| 粗利率 | — | — |
| 営業利益率 | 1.9% | 11.4% |
| 純利益率 | 0.7% | 6.9% |
| 売上前年比 | 42.9% | 10.7% |
| 純利益前年比 | 184.4% | -9.8% |
| EPS（希薄化後） | $0.12 | $1.71 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $442.0M | ||
| Q3 25 | $956.0M | $441.3M | ||
| Q2 25 | $654.8M | $411.8M | ||
| Q1 25 | $620.4M | $404.1M | ||
| Q4 24 | $665.2M | $399.3M | ||
| Q3 24 | $478.7M | $378.1M | ||
| Q2 24 | $486.3M | $381.0M | ||
| Q1 24 | $404.4M | $363.4M |
| Q4 25 | $6.6M | $30.7M | ||
| Q3 25 | $373.0K | $30.4M | ||
| Q2 25 | $9.4M | $19.4M | ||
| Q1 25 | $6.7M | $24.5M | ||
| Q4 24 | $-7.8M | $34.0M | ||
| Q3 24 | $16.1M | $27.1M | ||
| Q2 24 | $19.2M | $37.5M | ||
| Q1 24 | $14.8M | $18.0M |
| Q4 25 | 1.9% | 11.4% | ||
| Q3 25 | 2.0% | 11.3% | ||
| Q2 25 | 3.1% | 11.1% | ||
| Q1 25 | 3.3% | 8.1% | ||
| Q4 24 | 0.1% | 11.8% | ||
| Q3 24 | 5.9% | 11.2% | ||
| Q2 24 | 6.2% | 15.6% | ||
| Q1 24 | 7.5% | 5.5% |
| Q4 25 | 0.7% | 6.9% | ||
| Q3 25 | 0.0% | 6.9% | ||
| Q2 25 | 1.4% | 4.7% | ||
| Q1 25 | 1.1% | 6.1% | ||
| Q4 24 | -1.2% | 8.5% | ||
| Q3 24 | 3.4% | 7.2% | ||
| Q2 24 | 3.9% | 9.8% | ||
| Q1 24 | 3.7% | 5.0% |
| Q4 25 | $0.12 | $1.71 | ||
| Q3 25 | $0.01 | $1.71 | ||
| Q2 25 | $0.19 | $1.09 | ||
| Q1 25 | $0.14 | $1.33 | ||
| Q4 24 | $-0.14 | $1.82 | ||
| Q3 24 | $0.33 | $1.47 | ||
| Q2 24 | $0.40 | $2.03 | ||
| Q1 24 | $0.31 | $0.95 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $24.5M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $779.3M | $528.6M |
| 総資産 | $2.2B | $1.5B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $24.5M | ||
| Q3 25 | $463.4M | $23.9M | ||
| Q2 25 | $342.1M | $61.0M | ||
| Q1 25 | $260.9M | $23.4M | ||
| Q4 24 | $290.8M | $21.9M | ||
| Q3 24 | $350.3M | $18.5M | ||
| Q2 24 | $327.7M | $17.6M | ||
| Q1 24 | $337.3M | $18.6M |
| Q4 25 | $779.3M | $528.6M | ||
| Q3 25 | $775.5M | $499.8M | ||
| Q2 25 | $765.5M | $475.0M | ||
| Q1 25 | $745.4M | $494.3M | ||
| Q4 24 | $712.7M | $561.3M | ||
| Q3 24 | $704.6M | $522.8M | ||
| Q2 24 | $678.9M | $500.6M | ||
| Q1 24 | $653.5M | $495.6M |
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.5B | ||
| Q2 25 | $1.4B | $1.5B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.2B | $1.3B |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $126.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $123.8M |
| FCFマージンFCF / 売上 | -0.6% | 28.0% |
| 設備投資強度設備投資 / 売上 | 0.3% | 0.6% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 4.12× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $183.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $126.4M | ||
| Q3 25 | $10.0M | $93.8M | ||
| Q2 25 | $90.9M | $80.0M | ||
| Q1 25 | $16.6M | $-106.8M | ||
| Q4 24 | $-10.9M | $139.6M | ||
| Q3 24 | $34.0M | $85.2M | ||
| Q2 24 | $23.2M | $107.2M | ||
| Q1 24 | $6.0M | $-130.7M |
| Q4 25 | $-6.0M | $123.8M | ||
| Q3 25 | $7.4M | $89.8M | ||
| Q2 25 | $89.5M | $78.0M | ||
| Q1 25 | $13.6M | $-108.7M | ||
| Q4 24 | $-13.5M | $137.0M | ||
| Q3 24 | $31.7M | $82.8M | ||
| Q2 24 | $20.4M | $104.7M | ||
| Q1 24 | $5.6M | $-131.9M |
| Q4 25 | -0.6% | 28.0% | ||
| Q3 25 | 0.8% | 20.3% | ||
| Q2 25 | 13.7% | 18.9% | ||
| Q1 25 | 2.2% | -26.9% | ||
| Q4 24 | -2.0% | 34.3% | ||
| Q3 24 | 6.6% | 21.9% | ||
| Q2 24 | 4.2% | 27.5% | ||
| Q1 24 | 1.4% | -36.3% |
| Q4 25 | 0.3% | 0.6% | ||
| Q3 25 | 0.3% | 0.9% | ||
| Q2 25 | 0.2% | 0.5% | ||
| Q1 25 | 0.5% | 0.5% | ||
| Q4 24 | 0.4% | 0.7% | ||
| Q3 24 | 0.5% | 0.6% | ||
| Q2 24 | 0.6% | 0.6% | ||
| Q1 24 | 0.1% | 0.3% |
| Q4 25 | -0.44× | 4.12× | ||
| Q3 25 | 26.69× | 3.08× | ||
| Q2 25 | 9.65× | 4.12× | ||
| Q1 25 | 2.48× | -4.35× | ||
| Q4 24 | — | 4.11× | ||
| Q3 24 | 2.11× | 3.14× | ||
| Q2 24 | 1.21× | 2.86× | ||
| Q1 24 | 0.40× | -7.26× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
HURN
| Consulting And Managed Services Capability | $172.9M | 39% |
| Education | $118.7M | 27% |
| Commercial | $91.9M | 21% |
| Digital Capability | $54.6M | 12% |
